Optimizing the management of relapsed chronic myeloid leukemia post-allogeneic bone marrow transplant

Leuk Lymphoma. 2015;56(10):3001-2. doi: 10.3109/10428194.2015.1032969. Epub 2015 Jun 19.

Authors

Joshua F Zeidner^{1

2}, B Douglas Smith¹

Affiliations

¹ a Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine , Baltimore , MD , USA.
² b Lineberger Comprehensive Cancer Center, University of North Carolina , Chapel Hill , NC , USA.

PMID: 25804770
DOI: 10.3109/10428194.2015.1032969

No abstract available

Publication types

Comment

MeSH terms

Bone Marrow Transplantation*
Graft vs Host Disease
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive*
Recurrence
Transplantation, Homologous